Introducing DiagnosysFST® as a unique method to determine visual threshold of rod and cone performance using either Diagnosys ColorDome® or ColorFlash stimulators.
With more than 15 years experience in clinical trials and over 45 peer-reviewed publications, DiagnosysFST is now enhanced for clinical use. Normative data is soon to be released.
DiagnosysFST continues to gain recognition as a necessary measurement of treatment efficacy in gene therapy trials for low vision patients.
We offer scotopic and photopic versions of all DiagnosysFST® protocols, each with a quality scoring metric to make interpretation simple.
Standard Protocols
